Products for Research Use Only
RegisterLogin

Tasurgratinib (E7090)

CAT: 0013-GTR19259628-01Size: 100 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19259628-01Size:100 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
E7090 (E 7090) is a highly potent and selective orally bioavailable inhibitor targeting FGFR1, FGFR2, and FGFR3, with IC50 values of 0.71 nM, 0.50 nM, and 1.2 nM, respectively. It exhibits significantly weaker inhibition of FGFR4, with an IC50 of 120 nM. This distinct selectivity profile positions E7090 as a promising therapeutic candidate for diseases driven by aberrant FGFR1-3 signaling, offering a targeted approach to inhibit these receptors while minimizing off-target effects on FGFR4. Its oral availability further enhances its potential as a convenient and effective treatment option for patients with FGFR-dependent conditions.
CAS Number
1622204-21-0
Purity
>98%
Molecular Formula
C32H37N5O6
Molecular Weight
587.677
Notes
For research use only.

Related Products

CatalogName
GTR19197712-01E7090
GTR19212556-01E7090 succinate

Alternative Products

CatalogName
BA8945-5.1E7090
527003Tasurgratinib
MBS5815043E7090 succinate
HY-101466RE7090 (Standard)
HY-101466A-01E7090 (succinate)

Popular Products